The Hirshberg Foundation is committed to advancing the most innovative science with the potential to change outcomes for pancreatic cancer patients. UCLA is home to many of the nation’s leading […]
Progress Towards a Less Invasive Treatment for Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors, also called PNETs or PanNETs, are the second most common type of pancreatic cancer after pancreatic ductal adenocarcinomas or PDACs. While PDACs arise from ductal or exocrine […]
Advancing the Field: Highlights from the 56th Annual APA Meeting
On November 12-15 2025, the American Pancreatic Association (APA) held their 56th annual meeting in San Diego, CA. This gathering brings together almost 500 clinicians and researchers from around the […]
Our 2025 UCLA Catalyst Grant Winners are Driving Research Towards Better Treatment Options
As we celebrate the 20th anniversary of our pioneering Seed Grant Program, we are proud to announce the launch of a new era in our mission to drive scientific breakthroughs: […]
Dr. Anna Gukovskaya: From Seed Grant to Global Recognition in Pancreatic Research
Our Seed Grant Program has fostered an environment where research can bloom. As we mark 20 years since our first cohort of grantees, it is inspiring to reflect on the […]
Safeguarding Critical Research & Momentum Amid Funding Cuts
The nationwide freeze on federal cancer research funding is a pivotal moment, with the future of countless discoveries hanging in the balance, for patients and for the scientists working on […]